Sonnet BioTherapeutics Holdings, Inc.·4

Jul 2, 6:25 PM ET

RUGG TERENCE ANTHONY 4

4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Jul 2, 2020

Insider Transaction Report

Form 4
Period: 2020-07-02
RUGG TERENCE ANTHONY
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2020-07-02+21,31421,314 total
Footnotes (1)
  • [F1]On July 2, 2020, the Reporting Person was granted 21,314 restricted stock units, which will be settled in shares of common stock, par value $0.000. The restricted stock units vest as to 50% of the restricted stock units on April 2, 2021 and 50% of the restricted stock units on April 2, 2022.

Documents

1 file
  • 4
    ownership.xmlPrimary